- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
- You can view the full Merck Ratings Report.
Here's what you need to know for Wednesday, April 25.
Investors shouldn't be so worried about President Trump's trade tariffs.
The tough news keeps coming at the generic drug company, which announced last week it was considering putting itself up for sale. Now the Justice Department wants a chat.
Stocks rise after stronger-than-expected earnings from Boeing and Twitter.
The markets aren't pricing in short-term geopolitical tail risks, according to Ian Bremmer, CEO of Eurasia Group and author of the new book Us vs. Them: The Failure of Globalism.